Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1200/GO.20.00220 http://scihub22266oqcxt.onion/10.1200/GO.20.00220 32639877!7392777!32639877     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JCO+Glob+Oncol 2020 ; 6 (ä): 1046-1051 Nephropedia Template TP {{tp|p=32639877|t=2020. Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers |pdf=|usr=}}{{32639877}} gab.com Text Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers JO: JCO Glob Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32639877 #FOAvip PURPOSE: Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, including rapid adoption of telemedicine-based care. We aimed to evaluate the impact of telemedicine on patients, clinicians, and care delivery at the Royal Marsden Hospital (RMH) Sarcoma Unit during the pandemic. METHODS: Data were extracted from patient records for all planned outpatient appointments at the RMH Sarcoma Unit from March 23 to April 24, 2020. Patients and clinicians completed separate questionnaires to understand their experiences. RESULTS: Of 379 planned face-to-face appointments, 283 (75%) were converted to telemedicine. Face-to-face appointments remained for patients who needed urgent start of therapy or performance status assessment. Patients lived on average > 1.5 hours from RMH. Patient satisfaction (n = 108) with telemedicine was high (mean, 9/10), and only 48% (n = 52/108) would not want to hear bad news using telemedicine. Clinicians found telemedicine efficient, with no associated increased workload, compared with face-to-face appointments. Clinicians indicated lack of physical examination did not often affect care provision when using telemedicine. Most clinicians (n = 17; 94%) believed telemedicine use was practice changing; congruently, 80% (n = 86/108) of patients desired some telemedicine as part of their future care, citing reduced cost and travel time. CONCLUSION: Telemedicine can revolutionize delivery of cancer care, particularly for patients with rare cancers who often live far away from expert centers. Our study demonstrates important patient and clinician benefits; assessment of longer-term impact on patient outcomes and health care systems is needed. Twit Text FOAVip Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers ????JCO Glob Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32639877 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32639877 #FOAvip English Wikipedia <ref>{{Cite pmid|32639877}}</ref> Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers #MMPMID32639877 Smrke A; Younger E; Wilson R; Husson O; Farag S; Merry E; Macklin-Doherty A; Cojocaru E; Arthur A; Benson C; Miah AB; Zaidi S; Gennatas S; Jones RL JCO Glob Oncol 2020[Jul]; 6 (ä): 1046-1051 PMID32639877show ga PURPOSE: Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, including rapid adoption of telemedicine-based care. We aimed to evaluate the impact of telemedicine on patients, clinicians, and care delivery at the Royal Marsden Hospital (RMH) Sarcoma Unit during the pandemic. METHODS: Data were extracted from patient records for all planned outpatient appointments at the RMH Sarcoma Unit from March 23 to April 24, 2020. Patients and clinicians completed separate questionnaires to understand their experiences. RESULTS: Of 379 planned face-to-face appointments, 283 (75%) were converted to telemedicine. Face-to-face appointments remained for patients who needed urgent start of therapy or performance status assessment. Patients lived on average > 1.5 hours from RMH. Patient satisfaction (n = 108) with telemedicine was high (mean, 9/10), and only 48% (n = 52/108) would not want to hear bad news using telemedicine. Clinicians found telemedicine efficient, with no associated increased workload, compared with face-to-face appointments. Clinicians indicated lack of physical examination did not often affect care provision when using telemedicine. Most clinicians (n = 17; 94%) believed telemedicine use was practice changing; congruently, 80% (n = 86/108) of patients desired some telemedicine as part of their future care, citing reduced cost and travel time. CONCLUSION: Telemedicine can revolutionize delivery of cancer care, particularly for patients with rare cancers who often live far away from expert centers. Our study demonstrates important patient and clinician benefits; assessment of longer-term impact on patient outcomes and health care systems is needed. |*Pandemics[MESH] |*Patient Satisfaction[MESH] |*Workload[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Ambulatory Care/*methods[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology[MESH] |Delivery of Health Care/methods[MESH] |Female[MESH] |Gastrointestinal Neoplasms/therapy[MESH] |Gastrointestinal Stromal Tumors/therapy[MESH] |Humans[MESH] |Male[MESH] |Medical Oncology/*methods[MESH] |Middle Aged[MESH] |Pneumonia, Viral/*epidemiology[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH] |Sarcoma/*therapy[MESH] |Soft Tissue Neoplasms/therapy[MESH] |Telemedicine/*methods[MESH] |Travel[MESH] |United Kingdom/epidemiology[MESH]Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Can(epmc).pdf DeepDyve Pubget Overpricing